Internal Medicine, Cardiovascular Disease · La Jolla, CA
NPI
1346355161
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
9300 Campus Point Dr
La Jolla, CA, 92037
Phone (858) 248-1308
Groups this clinician bills Medicare through
Medicare paid, 2024
$84K
1,860 services
Medicare patients, 2024
914
Average age 73
Drug cost, 2024
$921K
3,030 prescriptions
Company payments, 2025
$281K
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Pam R Taub was code 93010 (electrocardiogram), 479 times for 389 patients. In total Pam R Taub billed 1,860 services in 31 codes, and Medicare paid $84K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-09-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93010 Electrocardiogram | Facility | 479 | 389 | $6.32 | $3,028 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 267 | 224 | $13.38 | $3,573 |
| 99214 Office E&M - Established | Facility | 226 | 197 | $69.74 | $16K |
| 93306 Echocardiography (TTE/TEE) | Facility | 197 | 190 | $52.06 | $10K |
| 99215 Office E&M - Established | Facility | 138 | 112 | $109.89 | $15K |
| 93306 Echocardiography (TTE/TEE) | Office | 120 | 115 | $150.82 | $18K |
| 99421 Office/Outpatient Services | Facility | 81 | 61 | $9.76 | $791 |
| 99213 Office E&M - Established | Facility | 46 | 44 | $39.89 | $1,835 |
| 93351 Echocardiography (TTE/TEE) | Facility | 34 | 33 | $60.75 | $2,066 |
| 76376 CT Scan | Office | 31 | 31 | $21.15 | $656 |
| 93000 Electrocardiogram | Office | 25 | 25 | $11.52 | $288 |
| 93356 Echocardiography (TTE/TEE) | Office | 24 | 24 | $32.37 | $777 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 19 | 16 | $13.50 | $257 |
| 76376 CT Scan | Facility | 17 | 17 | $7.22 | $123 |
| 99204 Office E&M - New | Facility | 16 | 16 | $101.01 | $1,616 |
By year: 2022 $75K for 1,526 services; 2023 $81K for 1,617 services; 2024 $84K for 1,860 services.
Medicare prescription drug claims, 2024
In 2024, the drug Pam R Taub prescribed most often to Medicare patients was Rosuvastatin Calcium, with 327 prescriptions and refills. In total Pam R Taub wrote 3,030 Medicare prescriptions that cost $921K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 327 | 928 | 97 | $5,698 |
| Eliquis Apixaban | 202 | 402 | 49 | $226K |
| Amlodipine Besylate Generic | 198 | 528 | 56 | $1,295 |
| Atorvastatin Calcium Generic | 175 | 508 | 62 | $2,076 |
| Metoprolol Succinate Generic | 129 | 385 | 46 | $1,810 |
| Ezetimibe Generic | 127 | 351 | 42 | $3,961 |
| Carvedilol Generic | 119 | 323 | 34 | $1,044 |
| Losartan Potassium Generic | 119 | 336 | 39 | $1,268 |
| Jardiance Empagliflozin | 115 | 255 | 30 | $140K |
| Repatha Sureclick Evolocumab | 110 | 159 | 18 | $88K |
| Furosemide Generic | 89 | 232 | 32 | $570 |
| Ozempic Semaglutide | 84 | 102 | 13 | $89K |
| Lisinopril Generic | 75 | 189 | 19 | $742 |
| Metformin Hcl Er Metformin Hcl | 74 | 202 | 26 | $604 |
| Xarelto Rivaroxaban | 59 | 168 | 16 | $91K |
Brand drugs: - claims; generic drugs: 2,226 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Pam R Taub $281K ($265K in general payments such as food, travel and fees and $16K for research) from 23 companies. The largest payer was Novo Nordisk AS with $88K.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk AS NVO | 17 | $88K |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 19 | $35K |
| Novartis Pharma AG NVS | 9 | $31K |
| Medtronic, Inc. MDT | 22 | $31K |
| Corcept Therapeutics CORT | 14 | $21K |
| Eli Lilly and Company LLY | 4 | $14K |
| Amgen Inc. AMGN | 8 | $13K |
| Merck Sharp & Dohme LLC MRK | 42 | $8,360 |
| Ionis Pharmaceuticals, Inc. IONS | 4 | $7,959 |
| Alnylam Pharmaceuticals Inc. ALNY | 1 | $5,250 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.